Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease.
Thevandavakkam
Mathuravani A
MA
Department of Genetics, University of Leicester, Leicester LE1 7RH, UK.
Schwarcz
Robert
R
Muchowski
Paul J
PJ
Giorgini
Flaviano
F